Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
The chromosome 21 kinase DYRK1A: emerging roles in cancer biology and potential as a therapeutic target.
Oncogene. 2022 Apr;41(14):2003-2011. doi: 10.1038/s41388-022-02245-6. Epub 2022 Feb 26.
Oncogene. 2022.
PMID: 35220406
Free PMC article.
Review.
DYRK1A regulates B cell acute lymphoblastic leukemia through phosphorylation of FOXO1 and STAT3.
Bhansali RS, Rammohan M, Lee P, Laurent AP, Wen Q, Suraneni P, Yip BH, Tsai YC, Jenni S, Bornhauser B, Siret A, Fruit C, Pacheco-Benichou A, Harris E, Besson T, Thompson BJ, Goo YA, Hijiya N, Vilenchik M, Izraeli S, Bourquin JP, Malinge S, Crispino JD.
Bhansali RS, et al. Among authors: rammohan m.
J Clin Invest. 2021 Jan 4;131(1):e135937. doi: 10.1172/JCI135937.
J Clin Invest. 2021.
PMID: 33393494
Free PMC article.
Item in Clipboard
Biological Characterization of 8-Cyclopropyl-2-(pyridin-3-yl)thiazolo[5,4-f]quinazolin-9(8H)-one, a Promising Inhibitor of DYRK1A.
Fruit C, Couly F, Bhansali R, Rammohan M, Lindberg MF, Crispino JD, Meijer L, Besson T.
Fruit C, et al. Among authors: rammohan m.
Pharmaceuticals (Basel). 2019 Dec 17;12(4):185. doi: 10.3390/ph12040185.
Pharmaceuticals (Basel). 2019.
PMID: 31861110
Free PMC article.
Item in Clipboard
Cite
Cite